MannKind Corporation (MNKD) Social Stream



MannKind Corporation (MNKD): $3.73

0.04 (-1.06%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add MNKD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#35 of 345

in industry

MANNKIND CORP (MNKD) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MANNKIND CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $6.5 $5 $5.8 $3.54 63.84%
2022-02-25 5 $6.5 $5 $5.9 $3.54 66.67%
2022-05-06 5 $6.5 $5 $5.6 $3.54 58.19%
2022-08-12 3 $6.5 $5 $5.75 $3.54 62.43%
2022-11-09 3 $6.5 $5.5 $6 $3.54 69.49%
2023-02-08 4 $6.5 $5.5 $6 $3.54 69.49%
2023-02-24 4 $7 $5.5 $6.25 $3.54 76.55%
2023-02-27 4 $7 $5.5 $6.5 $3.54 83.62%
2023-05-11 4 $7 $6.5 $6.833 $3.54 93.02%
2023-08-07 4 $7 $6.5 $6.75 $3.54 90.68%
2023-08-08 4 $7.5 $6.5 $7 $3.54 97.74%
2023-08-14 4 $7.5 $6.5 $7.125 $3.54 101.27%
2023-11-08 5 $10 $6.5 $7.7 $3.54 117.51%
2023-11-13 5 $10 $5.5 $7.3 $3.54 106.21%

The Trend in the Analyst Price Target


MNKD's average price target has moved up $1.3 over the prior 12 months.

MNKD reports an average of 56.72% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 4 6.5 5.5 6.00 5.10 17.65%
2023-02-27 4 7.0 6.5 6.75 5.38 25.46%
2023-05-10 4 7.0 6.5 6.75 4.40 53.41%
2023-07-10 4 7.0 6.5 6.75 4.12 63.83%
2023-08-08 4 7.5 6.5 7.00 5.45 28.44%

MNKD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


MNKD's average broker recommendation rating improved by 0 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MNKD as an investment opportunity.

  • In the context of all US stocks, MANNKIND CORP's average analyst price target is greater than 96.8% of them.
  • MANNKIND CORP's number of analysts covering the stock is greater than 227.04% of stocks in the mid market cap category.
  • In the context of Pharmaceutical Products stocks, MANNKIND CORP's variance in analysts' estimates is lower than -130.85% of them.
  • In the context of stocks in the mid market cap category, MANNKIND CORP's upside potential (average analyst target price relative to current price) is higher than 1121.25% of them.

In the Pharmaceutical Products industry, AMRN, LGND, and ARWR are the three stocks most similar to MANNKIND CORP regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding MNKD using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!